🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/05/2021 | 191,64 | 196,72 | 191,06 | 195,42 | +1,74% | 2,95% | 170.600 |
| 06/05/2021 | 197,79 | 197,79 | 189,41 | 192,07 | -3,06% | 4,24% | 307.800 |
| 05/05/2021 | 195,37 | 201,65 | 188,92 | 198,14 | +1,42% | 6,52% | 425.900 |
| 04/05/2021 | 201,89 | 202,84 | 194,03 | 195,37 | -3,18% | 4,36% | 349.200 |
| 03/05/2021 | 203,07 | 205,86 | 200,47 | 201,79 | +0,11% | 2,65% | 326.300 |
| 30/04/2021 | 202,91 | 204,26 | 200,57 | 201,56 | -1,31% | 1,82% | 272.900 |
| 29/04/2021 | 205,25 | 205,25 | 201,42 | 204,24 | -0,67% | 1,87% | 196.300 |
| 28/04/2021 | 204,88 | 207,42 | 202,05 | 205,62 | +0,63% | 2,62% | 193.700 |
| 27/04/2021 | 208,96 | 208,96 | 204,21 | 204,33 | -1,82% | 2,27% | 263.100 |
| 26/04/2021 | 209,05 | 209,22 | 205,05 | 208,11 | +0,29% | 1,99% | 171.400 |
| 23/04/2021 | 210,66 | 210,66 | 205,21 | 207,50 | -0,87% | 2,59% | 233.000 |
| 22/04/2021 | 210,31 | 212,62 | 206,48 | 209,33 | -1,23% | 2,92% | 194.000 |
| 21/04/2021 | 208,63 | 212,15 | 207,74 | 211,93 | +2,10% | 2,11% | 346.600 |
| 20/04/2021 | 204,46 | 208,63 | 204,46 | 207,58 | +1,83% | 2,04% | 229.300 |
| 19/04/2021 | 204,95 | 205,18 | 201,02 | 203,84 | +0,05% | 2,03% | 303.600 |
| 16/04/2021 | 203,34 | 205,52 | 200,94 | 203,73 | +1,02% | 2,25% | 403.200 |
| 15/04/2021 | 203,05 | 203,89 | 201,02 | 201,67 | -0,55% | 1,41% | 255.500 |
| 14/04/2021 | 199,42 | 204,35 | 198,44 | 202,78 | +1,75% | 2,96% | 368.600 |
| 13/04/2021 | 199,71 | 203,08 | 197,08 | 199,30 | +0,36% | 3,00% | 413.600 |
| 12/04/2021 | 203,35 | 203,48 | 197,98 | 198,59 | -2,35% | 2,70% | 324.200 |
| 09/04/2021 | 199,85 | 204,78 | 198,79 | 203,36 | +1,31% | 3,00% | 586.100 |
| 08/04/2021 | 194,99 | 200,93 | 192,16 | 200,73 | +5,04% | 4,50% | 991.500 |
| 07/04/2021 | 191,67 | 193,75 | 188,34 | 191,10 | -0,29% | 2,82% | 1.019.800 |
| 06/04/2021 | 192,11 | 197,30 | 191,01 | 191,65 | -0,57% | 3,27% | 579.200 |
| 05/04/2021 | 192,45 | 195,13 | 191,03 | 192,75 | +0,21% | 2,13% | 440.100 |
| 01/04/2021 | 184,96 | 200,00 | 182,20 | 192,34 | +14,99% | 9,62% | 1.699.500 |
| 31/03/2021 | 167,40 | 170,05 | 165,75 | 167,27 | +1,09% | 2,57% | 655.800 |
| 30/03/2021 | 170,39 | 171,36 | 164,19 | 165,47 | -2,37% | 4,21% | 357.400 |
| 29/03/2021 | 169,77 | 173,36 | 167,90 | 169,49 | -1,00% | 3,22% | 307.900 |
| 26/03/2021 | 168,35 | 171,44 | 166,76 | 171,21 | +1,70% | 2,78% | 244.000 |